1.2K
Articles
32K
Citations
3.6
avg. Impact Factor
79
h-index

Most Cited Articles of Division of Medical Oncology

TitleJournalYearCitations
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockadeScience20173.3K
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 MutationNew England Journal of Medicine20171.1K
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitisJAMA - Journal of the American Medical Association2007928
Prevalence of oral HPV infection in the United States, 2009-2010JAMA - Journal of the American Medical Association2012718
Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cellsCancer Cell2013506
Cytogenetics in acute leukemiaBlood Reviews2004506
Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group studyJournal of Clinical Oncology2000501
Side effects of adjuvant treatment of breast cancerNew England Journal of Medicine2001488
Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabineProceedings of the National Academy of Sciences of the United States of America2010399
What does it take to make a natural killer?Nature Reviews Immunology2003388
Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancerJournal of Clinical Oncology2001375
In vivo evidence for a dependence on interleukin 15 for survival of natural killer cellsBlood2002341
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responsesProceedings of the National Academy of Sciences of the United States of America2006291
Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutationsGastroenterology2014269
Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instabilityGenome Research2014259
IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancerGut2018255
Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomasOral Oncology2013245
Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1)Molecular and Cellular Biology2006236
Comprehensive control of human papillomavirus infections and related diseasesVaccine2013230
Molecular markers identify subtypes of stage III colon cancer associated with patient outcomesGastroenterology2015219
Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendationsBiology of Blood and Marrow Transplantation2014218
Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosisVaccine2012191
An oncolytic HSV-1 mutant expressing ICP34.5 under control of a nestin promoter increases survival of animals even when symptomatic from a brain tumorCancer Research2005183
HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patientsJournal of Clinical Oncology2006173
Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissueImmunity2010167